These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 27387680)

  • 1. 8q24 Polymorphisms and Diabetes Mellitus Regulate Apolipoprotein A-IV in Colorectal Carcinogenesis.
    Sugimachi K; Yamaguchi R; Eguchi H; Ueda M; Niida A; Sakimura S; Hirata H; Uchi R; Shinden Y; Iguchi T; Morita K; Yamamoto K; Miyano S; Mori M; Maehara Y; Mimori K
    Ann Surg Oncol; 2016 Aug; 23(Suppl 4):546-551. PubMed ID: 27387680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic copy number of a carcinogenic single nucleotide polymorphism at 8q24 in non-risk allele colorectal cancer associated with insulin growth factor 2 receptor expression.
    Takahashi Y; Mimori K; Yamamoto K; Watanabe M; Tanaka J; Kudo SE; Sugihara K; Hase K; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Mori M
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():95-9. PubMed ID: 22486879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk for CRC in diabetic patients with the nonrisk allele of SNPs at 8q24.
    Ishimaru S; Mimori K; Yamamoto K; Inoue H; Imoto S; Kawano S; Yamaguchi R; Sato T; Toh H; Iinuma H; Maeda T; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Sugihara K; Hase K; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Barnard GF; Miyano S; Mori M
    Ann Surg Oncol; 2012 Sep; 19(9):2853-8. PubMed ID: 22434246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic imbalance at an 8q24 oncogenic SNP is involved in activating MYC in human colorectal cancer.
    Sugimachi K; Niida A; Yamamoto K; Shimamura T; Imoto S; Iinuma H; Shinden Y; Eguchi H; Sudo T; Watanabe M; Tanaka J; Kudo S; Hase K; Kusunoki M; Yamada K; Shimada Y; Sugihara K; Maehara Y; Miyano S; Mori M; Mimori K
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S515-21. PubMed ID: 24390711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Single nucleotide polymorphisms associated with the oncogenesis of colorectal cancer.
    Mimori K; Tanaka F; Shibata K; Mori M
    Surg Today; 2012 Feb; 42(3):215-9. PubMed ID: 22127532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P; Muzík J; Benedík J; Znojil V; Vácha J
    Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence that associations of incident, sporadic colorectal adenoma with its major modifiable risk factors differ by chromosome 8q24 region rs6983267 genotype.
    Yang B; Thyagarajan B; Gross MD; Fedirko V; Goodman M; Bostick RM
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E193-200. PubMed ID: 24115145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-IV in diabetes mellitus.
    Verges B
    Diabete Metab; 1995 Apr; 21(2):99-105. PubMed ID: 7621979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas.
    Yang B; Thyagarajan B; Gross MD; Goodman M; Sun YV; Bostick RM
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E187-92. PubMed ID: 23776012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ApoA-II -265T/C polymorphism and oxidative stress in patients with type 2 diabetes mellitus.
    Koohdani F; Sadrzadeh-Yeganeh H; Djalali M; Eshraghian M; Keramat L; Mansournia MA; Zamani E
    J Diabetes Complications; 2015; 29(7):908-12. PubMed ID: 26104730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.
    Lu S; Bevier M; Huhn S; Sainz J; Lascorz J; Pardini B; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Int J Cancer; 2013 Nov; 133(10):2325-33. PubMed ID: 23650115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians.
    Oskina NA; Boyarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
    Urol Oncol; 2014 Jan; 32(1):37.e7-12. PubMed ID: 23628314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.
    Kollerits B; Krane V; Drechsler C; Lamina C; März W; Ritz E; Wanner C; Kronenberg F;
    J Intern Med; 2012 Dec; 272(6):592-600. PubMed ID: 22891946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with alpha-catenin: implications for inflammatory bowel diseases.
    Orsó E; Moehle C; Boettcher A; Szakszon K; Werner T; Langmann T; Liebisch G; Buechler C; Ritter M; Kronenberg F; Dieplinger H; Bornstein SR; Stremmel W; Schmitz G
    Horm Metab Res; 2007 Aug; 39(8):601-11. PubMed ID: 17712726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
    Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
    Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk.
    Sainz J; Rudolph A; Hoffmeister M; Frank B; Brenner H; Chang-Claude J; Hemminki K; Försti A
    J Clin Endocrinol Metab; 2012 May; 97(5):E845-51. PubMed ID: 22419714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample.
    Schafmayer C; Buch S; Völzke H; von Schönfels W; Egberts JH; Schniewind B; Brosch M; Ruether A; Franke A; Mathiak M; Sipos B; Henopp T; Catalcali J; Hellmig S; ElSharawy A; Katalinic A; Lerch MM; John U; Fölsch UR; Fändrich F; Kalthoff H; Schreiber S; Krawczak M; Tepel J; Hampe J
    Int J Cancer; 2009 Jan; 124(1):75-80. PubMed ID: 18839428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
    Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
    PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.